Colgate Q2: Sales Up 12%, Price Below Trendline

COLPAL reported Q2 FY27 net sales of Rs 1,692 crore, up 12.2% year-on-year, with H1 growth at 12.1%. Net profit rose 4.3% to Rs 341.6 crore (5.5% excluding one-offs), lagging sales because total expenses grew about 16%. Gross margin improved 40 basis points to 69.6%. Management said toothpaste delivered high-single-digit volume growth, led by the premium range and MaxFresh. An interim dividend of Rs 24 per share was declared, with a record date of 2 November. The shares settled near Rs 1,685, down about 2.3% on results day. On the monthly chart, the stock is more than 50% below its 2024 peak. It has moved below a rising trendline drawn from the 2016 low, as well as the 1,820 horizontal level, and RSI at 37.39 is weak. The month isn’t over, so the monthly close is what matters. A close below would confirm the breakdown, while a recovery above 1,820 would bring price back to the trendline. Support: 1,430-1,460 (2023 lows). Resistance: 1,820. Sales growth does not always become profit growth, and a monthly close, not a mid-month price, shows whether a long-term trendline has given way. Disclaimer: This is for educational purposes only and is not investment advice. Please consult your financial advisor before making any investment decisions. SEBI Registered Research Analyst — INH000025212. Source: Company Q2 FY27 results, as reported by Indian Television, inkl and Investywise.